Cost-Effectiveness Considerations for Disease Intervention
Sex Transm Dis
.
2023 Aug 1;50(8S Suppl 1):S28-S30.
doi: 10.1097/OLQ.0000000000001727.
Epub 2022 Nov 1.
Authors
Austin M Williams
1
,
Thomas L Gift
Affiliation
1
From the Clinical, Economics, and Health Services Research Branch, Division of STD Prevention, Centers for Disease Control and Prevention, Atlanta, GA.
PMID:
36394898
PMCID:
PMC10149544
DOI:
10.1097/OLQ.0000000000001727
No abstract available
MeSH terms
Cost-Benefit Analysis
Cost-Effectiveness Analysis*
Humans
Quality-Adjusted Life Years
Grants and funding
CC999999/ImCDC/Intramural CDC HHS/United States